Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer

Clinical trial NCT00429299 · COMPLETED

Trial details

NCT number: NCT00429299
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2006-08-01
Primary completion: 2012-06-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.